Fundraising Fox

Ikarian Capital

Venture capital

Dallas · Pre-Seed–Late Stage

Also known as IKARIAN CAPITAL, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Ikarian Capital invests in biotech companies advancing drug discovery and development, led by a team with scientific and biotech-specific finance expertise. It selects companies pursuing cutting-edge science with sound business fundamentals across the spectrum of early- to late-stage clinical trials, remaining agnostic to indication, market cap, and geography. The firm deploys transformational, long-term capital to support emerging companies as they progress through the clinic. It emphasizes a selective, contrarian approach backed by a proprietary process aligned with the team's core expertise, and is committed to building an enduring business with strong values and high ethical standards.

Invests inBiotechDallasGlobal

Source: firm website, verified Aug 2, 2026.

Stage
Pre-Seed–Late Stage
HQ
Dallas, US
AUM
$698M

Frequently asked questions

What stage does Ikarian Capital invest at?
Ikarian Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Ikarian Capital focus on?
Ikarian Capital focuses on Biotech.
Where is Ikarian Capital located?
Ikarian Capital is headquartered in Dallas, US.

Similar investors

Featured in lists